ArticleMolecules (Basel, Switzerland)2023

Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.